Aetion Scoops Up $110M Series C Round
Aetion Scoops Up $110M Series C Round Back to HomeNEW YORK, NY, Health care technology company Aetion announced today a $110 million Series C fundraise. The round was led by Warburg Pincus, a leading global growth equity firm, with additional investments from B Capital and Foresite Capital. The capital infusion supports Aetion's continued growth and industry leadership in the real-world evidence (RWE) space. Aetion delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence PlatformÂ® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value.